IMGO Insider Trading (Imago BioSciences)
Insider Ownership Percentage: 14.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,125,260.00
Imago BioSciences Share Price & Price History
Current Price: $18.36
Price Change: ▲ Price Increase of +1.21 (7.06%)
As of 08/12/2022 01:00 AM ET
Potential 500% Return From A Unique $1 Asset?
From Investing Daily | Ad
Millions are rushing towards life at “Ground Zero”.
A frightening new financial reality that has the potential to erase the wealth of millions. It’s largely avoidable if you know what to look for.
It all hinges on a single $1 asset that skyrockets during strange times like these.
Discover it now
>>>
Imago BioSciences Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
7/20/2022 | Laura G. Eichorn | Insider | Sell | 1,000 | $18.00 | $18,000.00 | 207,737 | |
2/22/2022 | Laura G. Eichorn | Insider | Sell | 8,000 | $21.60 | $172,800.00 | | |
2/11/2022 | Jennifer Peppe | Insider | Sell | 7,000 | $23.76 | $166,320.00 | | |
2/9/2022 | Jennifer Peppe | Insider | Sell | 10,000 | $22.26 | $222,600.00 | | |
2/7/2022 | Jennifer Peppe | Insider | Sell | 13,000 | $20.48 | $266,240.00 | | |
1/12/2022 | Jennifer Peppe | Insider | Sell | 14,000 | $19.95 | $279,300.00 | | |
A One Stop Shop for Everything Futures Trading
From RJO Futures | Ad
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.
Imago BioSciences Institutional Trading History
Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
---|
8/13/2022 | American International Group Inc. | 12,316 | $0.17M | 0.0% | +23.6% | 0.037% |  |
8/13/2022 | AlpInvest Partners B.V. | 30,156 | $0.40M | 0.1% | -66.7% | 0.089% |  |
8/12/2022 | Northern Trust Corp | 225,011 | $3.01M | 0.0% | +27.6% | 0.667% |  |
8/12/2022 | Ensign Peak Advisors Inc | 40,567 | $0.54M | 0.0% | +46.9% | 0.120% |  |
8/12/2022 | Credit Suisse AG | 8,874 | $0.12M | 0.0% | N/A | 0.026% |  |
8/12/2022 | FMR LLC | 5,060,365 | $67.76M | 0.0% | +4.4% | 14.998% |  |
8/12/2022 | Rhumbline Advisers | 32,755 | $0.44M | 0.0% | +83.2% | 0.097% |  |
8/11/2022 | Trexquant Investment LP | 32,045 | $0.43M | 0.0% | N/A | 0.095% |  |
8/11/2022 | Alps Advisors Inc. | 20,013 | $0.27M | 0.0% | -41.9% | 0.059% |  |
8/11/2022 | JPMorgan Chase & Co. | 15,522 | $0.21M | 0.0% | -75.3% | 0.046% |  |
8/9/2022 | Swiss National Bank | 31,800 | $0.43M | 0.0% | +14.4% | 0.094% |  |
8/4/2022 | TD Asset Management Inc. | 48,973 | $0.66M | 0.0% | -15.4% | 0.145% |  |
8/3/2022 | Regency Capital Management Inc. DE | 18,050 | $0.24M | 0.3% | N/A | 0.053% |  |
7/29/2022 | Emerald Mutual Fund Advisers Trust | 699,986 | $9.37M | 0.5% | +38.2% | 2.075% |  |
7/29/2022 | Emerald Advisers LLC | 823,062 | $11.02M | 0.6% | +33.5% | 2.440% |  |
6/30/2022 | Amalgamated Bank | 2,145 | $41K | 0.0% | N/A | 0.006% |  |
6/7/2022 | Bank of America Corp DE | 19,536 | $0.38M | 0.0% | +218.1% | 0.058% |  |
5/17/2022 | Ensign Peak Advisors Inc | 27,610 | $0.53M | 0.0% | +10.4% | 0.082% |  |
5/16/2022 | California State Teachers Retirement System | 18,672 | $0.36M | 0.0% | +25.0% | 0.055% |  |
5/16/2022 | Goldman Sachs Group Inc. | 94,827 | $1.83M | 0.0% | +8.1% | 0.281% |  |
5/16/2022 | Matrix Capital Management Company LP | 308,044 | $5.94M | 0.1% | N/A | 0.914% |  |
5/16/2022 | Blackstone Inc. | 2,436,732 | $46.96M | 0.1% | -27.8% | 7.229% |  |
5/16/2022 | Woodline Partners LP | 831,830 | $16.03M | 0.3% | -1.9% | 2.468% |  |
5/16/2022 | State Street Corp | 258,831 | $4.99M | 0.0% | +71.6% | 0.768% |  |
5/16/2022 | Frazier Life Sciences Management L.P. | 2,971,274 | $57.26M | 4.9% | N/A | 8.815% |  |
5/16/2022 | UBS Group AG | 1,288 | $25K | 0.0% | -71.8% | 0.004% |  |
5/13/2022 | Ameritas Investment Partners Inc. | 1,556 | $30K | 0.0% | +108.3% | 0.005% |  |
5/13/2022 | Northern Trust Corp | 176,333 | $3.40M | 0.0% | +64.6% | 0.523% |  |
5/13/2022 | Charles Schwab Investment Management Inc. | 48,250 | $0.93M | 0.0% | +91.6% | 0.143% |  |
5/13/2022 | AlpInvest Partners B.V. | 90,469 | $1.74M | 0.6% | N/A | 0.268% |  |
5/13/2022 | American International Group Inc. | 9,964 | $0.19M | 0.0% | +92.3% | 0.030% |  |
5/13/2022 | Parkman Healthcare Partners LLC | 139,751 | $2.69M | 0.8% | +27.0% | 0.415% |  |
5/13/2022 | Vanguard Group Inc. | 793,101 | $15.28M | 0.0% | +68.8% | 2.353% |  |
5/12/2022 | BlackRock Inc. | 3,290,894 | $63.42M | 0.0% | +146.2% | 9.763% |  |
5/12/2022 | Rhumbline Advisers | 17,881 | $0.35M | 0.0% | N/A | 0.053% |  |
5/12/2022 | Metropolitan Life Insurance Co NY | 1,473 | $28K | 0.0% | N/A | 0.004% |  |
5/12/2022 | MetLife Investment Management LLC | 12,570 | $0.24M | 0.0% | N/A | 0.037% |  |
5/12/2022 | Citigroup Inc. | 1,872 | $36K | 0.0% | -48.9% | 0.006% |  |
5/11/2022 | Bank of New York Mellon Corp | 51,629 | $1M | 0.0% | +84.6% | 0.153% |  |
5/11/2022 | JPMorgan Chase & Co. | 62,727 | $1.21M | 0.0% | +827.5% | 0.186% |  |
5/10/2022 | TD Asset Management Inc. | 57,873 | $1.12M | 0.0% | +182.7% | 0.172% |  |
5/9/2022 | Swiss National Bank | 27,800 | $0.54M | 0.0% | +7.8% | 0.082% |  |
5/5/2022 | New York State Common Retirement Fund | 13,391 | $0.26M | 0.0% | +106.6% | 0.040% |  |
4/29/2022 | Emerald Mutual Fund Advisers Trust | 506,358 | $9.76M | 0.4% | -6.3% | 1.502% |  |
4/29/2022 | Emerald Advisers LLC | 616,368 | $11.88M | 0.5% | +7.0% | 1.829% |  |
2/19/2022 | Woodline Partners LP | 848,129 | $20.11M | 0.3% | +101.9% | 2.530% |  |
2/15/2022 | Kennedy Capital Management Inc. | 53,903 | $1.28M | 0.0% | -8.9% | 0.161% |  |
2/15/2022 | Adage Capital Partners GP L.L.C. | 275,000 | $6.52M | 0.0% | -30.3% | 0.820% |  |
2/14/2022 | Citadel Advisors LLC | 2,452,926 | $57.27M | 0.0% | +20.1% | 7.316% |  |
2/14/2022 | Virtus ETF Advisers LLC | 9,065 | $0.22M | 0.1% | N/A | 0.027% |  |
2/11/2022 | Ensign Peak Advisors Inc | 25,000 | $0.59M | 0.0% | N/A | 0.075% |  |
2/9/2022 | Alps Advisors Inc. | 38,802 | $0.92M | 0.0% | N/A | 0.116% |  |
2/8/2022 | Swiss National Bank | 25,800 | $0.61M | 0.0% | N/A | 0.077% |  |
2/8/2022 | Northern Trust Corp | 107,122 | $2.54M | 0.0% | +25.0% | 0.319% |  |
2/2/2022 | New York State Common Retirement Fund | 6,482 | $0.15M | 0.0% | N/A | 0.019% |  |
2/2/2022 | Emerald Mutual Fund Advisers Trust | 540,364 | $12.81M | 0.5% | +1.1% | 1.612% |  |
2/2/2022 | Emerald Advisers LLC | 576,159 | $13.66M | 0.5% | +0.7% | 1.718% |  |
1/28/2022 | Allspring Global Investments Holdings LLC | 3,967 | $94K | 0.0% | N/A | 0.012% |  |
12/3/2021 | Perceptive Advisors LLC | 125,000 | $2.50M | 0.0% | N/A | 0.373% |  |
11/16/2021 | Citadel Advisors LLC | 2,042,439 | $40.12M | 0.0% | N/A | 6.109% |  |
11/15/2021 | Kingdon Capital Management L.L.C. | 173,830 | $3.48M | 0.4% | N/A | 0.520% |  |
11/15/2021 | Farallon Capital Management LLC | 2,671,313 | $53.51M | 0.3% | N/A | 7.990% |  |
11/12/2021 | StepStone Group LP | 522,987 | $8.37M | 0.5% | N/A | 1.564% |  |
11/12/2021 | Geode Capital Management LLC | 144,814 | $2.90M | 0.0% | N/A | 0.433% |  |
11/10/2021 | Citigroup Inc. | 1,507 | $30K | 0.0% | N/A | 0.005% |  |
11/9/2021 | BlackRock Inc. | 1,124,493 | $22.52M | 0.0% | N/A | 3.364% |  |
11/9/2021 | TD Asset Management Inc. | 20,473 | $0.41M | 0.0% | N/A | 0.061% |  |
11/4/2021 | Deutsche Bank AG | 5,606 | $0.11M | 0.0% | N/A | 0.017% |  |
10/28/2021 | Emerald Mutual Fund Advisers Trust | 534,644 | $10.71M | 0.4% | N/A | 1.599% |  |
10/28/2021 | Emerald Advisers LLC | 572,029 | $11.46M | 0.4% | N/A | 1.711% |  |
Data available starting January 2016
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Read More on Imago BioSciences
Today's Range
Now: $18.36
52 Week Range
Now: $18.36
Volume
57,159 shs
Average Volume
108,867 shs
Market Capitalization
$619.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Imago BioSciences?
Who are the major institutional investors of Imago BioSciences?
Which institutional investors are selling Imago BioSciences stock?
During the last quarter, IMGO stock was sold by these institutional investors:
- AlpInvest Partners B.V.
- JPMorgan Chase & Co.
- Alps Advisors Inc.
- TD Asset Management Inc.
During the previous year, company insiders that have sold Imago BioSciences company stock include:
- Laura G Eichorn (Insider)
- Jennifer Peppe (Insider)
Learn More investors selling Imago BioSciences stock.
Which institutional investors are buying Imago BioSciences stock?
In the previous quarter, IMGO stock was acquired by institutional investors including:
- FMR LLC
- Emerald Advisers LLC
- Emerald Mutual Fund Advisers Trust
- Northern Trust Corp
- Trexquant Investment LP
- Regency Capital Management Inc. DE
- Rhumbline Advisers
- Ensign Peak Advisors Inc